MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

Search

Embecta Corp

Closed

SectorHealthcare

10.9 -3.71

Overview

Share price change

24h

Current

Min

10.82

Max

11.14

Key metrics

By Trading Economics

Income

-41M

-26M

Sales

-24M

262M

P/E

Sector Avg

12.02

59.668

EPS

0.65

Dividend yield

5.04

Profit margin

-10.042

Employees

2,100

EBITDA

5.1M

39M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+80.78% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

5.04%

2.62%

Next Earnings

8 May 2025

Next Dividend date

13 Jun 2025

Market Stats

By TradingEconomics

Market Cap

692M

Previous open

14.61

Previous close

10.9

News Sentiment

By Acuity

50%

50%

169 / 385 Healthcare

Embecta Corp Chart

Past performance is not a reliable indicator of future results.

Related News

21 Apr 2025, 23:56 UTC

Acquisitions, Mergers, Takeovers

Nomura to Buy Macquarie's U.S., European Public Asset Management Business

21 Apr 2025, 22:37 UTC

Acquisitions, Mergers, Takeovers

Hino Motors, Mitsubishi Fuso Moving Toward Merger, Nikkei Says

21 Apr 2025, 23:58 UTC

Market Talk

Transurban on Bumpy Road During NSW Toll Review -- Market Talk

21 Apr 2025, 23:46 UTC

Market Talk

Gold Rises Amid Likely Safe-Haven Demand -- Market Talk

21 Apr 2025, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

21 Apr 2025, 23:43 UTC

Market Talk

Nikkei May Decline as Uncertainty Over U.S. Trade Policy Continues -- Market Talk

21 Apr 2025, 23:22 UTC

Acquisitions, Mergers, Takeovers

Nomura to Pay $1.8B for Macquarie's U.S. and European Public Asset-Management Business

21 Apr 2025, 23:22 UTC

Acquisitions, Mergers, Takeovers

Nomura to Acquire Macquarie's U.S. and European Public Asset-Management Business

21 Apr 2025, 22:35 UTC

Top News

Harvard Is Suing the Trump Administration -- 2nd Update

21 Apr 2025, 22:02 UTC

Top News

Harvard Is Suing the Trump Administration -- Update

21 Apr 2025, 21:46 UTC

Top News

Fed, Tariff Fears Send Dow Down More than 900 Points -- Update

21 Apr 2025, 21:03 UTC

Top News

3M Earnings Will Be Scoured for Tariff Impacts -- Barrons.com

21 Apr 2025, 21:03 UTC

Top News

Harvard Is Suing the Trump Administration -- WSJ

21 Apr 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

21 Apr 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

21 Apr 2025, 20:43 UTC

Top News

GE Aerospace Investors Are Hoping for Reassurance, and Strong Earnings -- Barrons.com

21 Apr 2025, 20:28 UTC

Top News

Fed, Tariff Fears Send Dow Down More than 900 Points -- WSJ

21 Apr 2025, 20:26 UTC

Top News

Lockheed Martin's Earnings Are Coming as Investors Watch the Pentagon -- Barrons.com

21 Apr 2025, 20:24 UTC

Top News

Dow and Dollar Drop on Jitters Over Fed and TradeHeadline -- WSJ

21 Apr 2025, 20:18 UTC

Top News

Boeing 737 MAX Jets in China Head Home. Can They Be Resold? -- Barrons.com

21 Apr 2025, 19:14 UTC

Market Talk

Oil Futures Give Back Pre-Holiday Gains -- Market Talk

21 Apr 2025, 19:11 UTC

Market Talk

U.S. Natural Gas Falls as China Turns Elsewhere for LNG -- Market Talk

21 Apr 2025, 19:07 UTC

Top News

Uber Faces FTC Lawsuit Alleging Deceptive Billing, Cancellation Practices -- Update

21 Apr 2025, 18:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21 Apr 2025, 18:44 UTC

Market Talk

Trump Seen as Unlikely to Fire Powell Despite Market Jitters -- Market Talk

21 Apr 2025, 18:28 UTC

Market Talk

Gold Finishes at New Record as Equities Slide -- Market Talk

21 Apr 2025, 18:26 UTC

Top News

Dow Industrials, Dollar Fall on Fed and Trade Concerns -- WSJ

21 Apr 2025, 16:27 UTC

Market Talk

Weaker Dollar No Longer Supporting Commodities Due to Fed Fears -- Market Talk

21 Apr 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

21 Apr 2025, 16:16 UTC

Top News

Dow and Dollar Drop on Jitters Over Fed and Trade -- WSJ

Peer Comparison

Price change

Embecta Corp Forecast

Price Target

By TipRanks

80.78% upside

12 Months Forecast

Average 20.5 USD  80.78%

High 26 USD

Low 15 USD

Based on 2 Wall Street analysts offering 12 month price targets forEmbecta Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Sentiment

By Acuity

169 / 385 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.